Reuters: DeepSeek Plans to Hire Hillhouse Ventures Partner Yan Wentao as CFO
nashnova research
DeepSeek plans to appoint GL Ventures partner Yan Wentao as its first-ever CFO — this means → the AI firm, valued at over $50 billion, is shifting fast from a research lab to a listing-ready corporate structure.
Who is Yan Wentao, and why him?
Yan, born in 1991, is a partner at GL Ventures — the venture arm of Hillhouse Investment, founded by Zhang Lei and focused on tech, biotech, and consumer sectors.
His portfolio includes AI developer MiniMax, a direct DeepSeek competitor.
One key detail: Hillhouse is not an investor in DeepSeek. In plain terms = DeepSeek recruited an outsider with AI-sector deal experience to run its finances, prioritizing expertise over capital ties.
Why does DeepSeek need a CFO now?
Founded in 2023, DeepSeek was fully funded by founder Liang Wenfeng's quant hedge fund High-Flyer. It only began seeking outside capital this year.
Reuters reported last week that DeepSeek has hired CITIC Securities to prepare a Shanghai STAR Market IPO, with the process set to begin this year — though timing, size, and target valuation remain undecided.
This means → a CFO is not a ceremonial title. Listing requires dedicated financial controls, investor relations, and disclosure workflows — someone has to own that full-time.
What is DeepSeek worth right now?
In June it closed roughly $7.4 billion in funding at a post-money valuation above $50 billion.
Reuters reported in July that a new round is underway, valuing the company at approximately 500 billion yuan (about $69 billion).
In plain terms = the valuation may climb nearly 40% within half a year — a pace that matches the market shock DeepSeek's low-cost models triggered earlier this year.
What is the next milestone to watch?
CFO in place + lead underwriter confirmed = the two major prerequisites for listing are now set.
This means → the next critical checkpoint is when the STAR Market filing timeline goes public — that is the line where DeepSeek's IPO moves from preparation to execution.
This reflects a company transforming at unusual speed from "Liang Wenfeng's lab" into a standalone entity with full corporate governance.
市场有风险，内容仅供研究参考，不构成投资建议。